MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6602-220-227$20.00
Mol Pharmacol 66:220-227, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patel, N. S. A.
Right arrow Articles by Thiemermann, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, N. S. A.
Right arrow Articles by Thiemermann, C.

Reduction of Renal Ischemia-Reperfusion Injury in 5-Lipoxygenase Knockout Mice and by the 5-Lipoxygenase Inhibitor Zileuton

Nimesh S. A. Patel, Salvatore Cuzzocrea, Prabal K. Chatterjee, Rosanna Di Paola, Lidia Sautebin, Domenico Britti, and Christoph Thiemermann

Centre for Experimental Medicine, Nephrology & Critical Care, William Harvey Research Institute, Queen Mary–University of London, United Kingdom (N.S.A.P., C.T.); Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Italy (S.C., R.D.P.); Department of Pharmacology, School of Pharmacy and Biomolecular Sciences, University of Brighton, United Kingdom (P.K.C.); Department of Experimental Pharmacology, University Federico II, Naples, Italy (L.S.); and Department of Veterinary and Agricultural Science, University of Teramo, Italy (D.B.)

The role of 5-lipoxygenase (5-LOX) in the pathophysiology of renal ischemia/reperfusion (I/R) injury is not known. Here we investigate the effects of 1) the 5-LOX inhibitor zileuton and 2) 5-LOX gene knockout (5-LOX/) mice on renal dysfunction and injury caused by I/R of the kidney in mice. Wild-type mice treated with zileuton (3 mg/kg i.v.) or 5-LOX/ mice were subjected to bilateral renal artery occlusion (30 min) followed by reperfusion (24 h). Plasma urea, creatinine, and aspartate aminotransferase (AST) were measured as markers of renal dysfunction and reperfusion injury. Kidneys were used for histological evaluation of renal injury. Renal myeloperoxidase activity was measured and used as an indicator of polymorphonuclear leukocyte (PMN) infiltration and renal expression of intercellular adhesion molecule-1 (ICAM-1) was determined using immunohistochemistry. Administration of zileuton before I/R significantly reduced the degree of renal dysfunction (urea, creatinine) and injury (AST, histology). In addition, zileuton reduced the expression of ICAM-1 and the associated PMN infiltration caused by I/R of the mouse kidney. Compared with wild-type mice, the degree of renal dysfunction, injury, and inflammation caused by I/R in 5-LOX/ mice was also significantly reduced, confirming the pathophysiological role of 5-LOX in the development of renal I/R injury. We propose that 1) endogenous 5-LOX metabolites enhance the degree of renal injury, dysfunction, and inflammation caused by I/R of the kidney by promoting the expression of adhesion molecules, and 2) inhibitors of 5-LOX may be useful in the treatment of conditions associated with I/R of the kidney.


Received December 12, 2003; accepted April 23, 2004

Address correspondence to: Prof. C. Thiemermann, Centre for Experimental Medicine, Nephrology & Critical Care, William Harvey Research Institute, Queen Mary - University of London, Charterhouse Square, London, EC1M 6BQ. E-mail: c.thiemermann{at}qmul.ac.uk




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. U. Norman, S. Hulliger, P. Colarusso, and P. Kubes
Multichannel Fluorescence Spinning Disk Microscopy Reveals Early Endogenous CD4 T Cell Recruitment in Contact Sensitivity via Complement
J. Immunol., January 1, 2008; 180(1): 510 - 521.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
T. Takajo, K. Tsuchida, T. Murahashi, K. Ueno, and I. Koshiishi
Intramolecular rearrangement of linolenate peroxyl radicals in lipoxygenase reactions at lower oxygen content
J. Lipid Res., April 1, 2007; 48(4): 855 - 862.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
N. S.A. Patel, U. Cortes, R. Di Poala, E. Mazzon, H. Mota-Filipe, S. Cuzzocrea, Z.-Q. Wang, and C. Thiemermann
Mice Lacking the 110-kD Isoform of Poly(ADP-Ribose) Glycohydrolase Are Protected against Renal Ischemia/Reperfusion Injury
J. Am. Soc. Nephrol., March 1, 2005; 16(3): 712 - 719.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Collin, A. Rossi, S. Cuzzocrea, N. S. A. Patel, R. Di Paola, J. Hadley, M. Collino, L. Sautebin, and C. Thiemermann
Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton
J. Leukoc. Biol., November 1, 2004; 76(5): 961 - 970.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics